This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: The Innovations of Moussa Youdim
Introduction
Moussa Youdim is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical research, particularly in the area of blood clotting factors. His work has the potential to impact the treatment of hemophilia, a condition that affects many individuals worldwide.
Latest Patents
Moussa Youdim holds a patent for the "Isolation and culture of adrenal medullary endothelial cells producing Factor VIII:C." This invention discloses a new line of endothelial cells of adrenal medullary origin that are capable of producing blood clotting Factor VIII:C. The method of isolating and culturing this cell line has also been detailed in the patent. Factor VIII:C is crucial for treating hemophilia, making this invention particularly valuable.
Career Highlights
Throughout his career, Moussa Youdim has demonstrated a commitment to advancing medical science. His innovative approach to isolating and culturing endothelial cells showcases his expertise and dedication to improving healthcare outcomes. He works for the United States of America as Represented by the Secretary of, contributing to important research initiatives.
Collaborations
Moussa Youdim has collaborated with notable colleagues, including Harvey B Pollard and Richard Ornberg. These partnerships have likely enhanced the scope and impact of his research efforts.
Conclusion
Moussa Youdim's contributions to the field of biomedical research, particularly through his patent on Factor VIII:C production, highlight his role as an innovative inventor. His work continues to pave the way for advancements in the treatment of hemophilia and other related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
